id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-348652-7n7rnonw	Ramos, Roberta Pulcheri	Thrombosis and anticoagulation in COVID-19	2020		.txt	text/plain	1024	60	46	Therefore, in patients with COVID-19 and a high pre-test probability of thrombotic events, especially in those with disproportionate hypoxemia, D-dimer levels should not contribute to the clinical decision-making to continue the investigation, because this test is more important for excluding the disease in populations with a low prevalence of VTE (< 10%). More importantly, the determination of D-dimer levels is of little use for the diagnosis of VTE when analyzed in isolation, especially in this high-risk population, in which the positive predictive value of the test is low. (12) To date, the best approach to treat patients with COVID-19 is to underscore the approach recommended for diseases with a high thrombotic risk: performing routine thromboprophylaxis in all hospitalized patients and increasing surveillance and clinical suspicion, especially in patients with gas exchange alterations disproportionate to the degree of systemic inflammation and the radiological findings.	./cache/cord-348652-7n7rnonw.txt	./txt/cord-348652-7n7rnonw.txt